Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer

Puvanenthiran, S., Essapen, S., Haagsma, B., Bagwan, I., Green, M., Khelwatty, S. A., Seddon, A. M. and Modjtahedi, H. (2018) Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer. Oncotarget, 9, pp. 19662-19674. ISSN (online) 1949-2553

Full text available as:
[img]
Preview
Text
Puvanenthiran-S-40813-VoR.pdf - Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview
Item Type: Article
Research Area: Biological sciences
Cancer studies
Chemistry
Faculty, School or Research Centre: Faculty of Science, Engineering and Computing (until 2017) > School of Life Sciences
Faculty of Science, Engineering and Computing (until 2017) > School of Pharmacy and Chemistry
Depositing User: Katrina Clifford
Date Deposited: 27 Apr 2018 14:52
Last Modified: 27 Apr 2018 14:52
DOI: https://doi.org/10.18632/oncotarget.24791
URI: http://eprints.kingston.ac.uk/id/eprint/40813

Actions (Repository Editors)

Item Control Page Item Control Page